HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N'- ((3Z)- 1- (1- hexyl)- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)benzohydrazide

for treatment of neuropathic pain

Also Known As:

MDA19

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrazines: 379
  - N'-((3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide: 3
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - N'-((3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide: 3

Experts

1.	Chen, Dongfeng: 1 article (01/2019)
2.	Jiang, Jianqing: 1 article (01/2019)
3.	Rao, Mei: 1 article (01/2019)
4.	Zhan, Peng: 1 article (01/2019)
5.	Dai, E-Nuo: 1 article (12/2018)
6.	Li, Jian-Min: 1 article (12/2018)
7.	Liu, Bin: 1 article (12/2018)
8.	Tian, Jia-Xin: 1 article (12/2018)
9.	Xu, Liang: 1 article (12/2018)
10.	Astruc-Diaz, Fanny: 1 article (07/2010)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2019 - "However, there is no study exploring the role of MDA19 (a novel CB2 agonist) in tumors. " 01/01/2019 - "In addition, we investigated the function of CB2receptor in HCC and its role in the anti-tumor activity of MDA19. "
2.	Osteosarcoma (Osteogenic Sarcoma) 12/21/2018 - "Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway."
3.	Neuralgia (Stump Neuralgia) 07/01/2010 - "MDA19 has potential for alleviating neuropathic pain without producing adverse effects in the central nervous system." 07/01/2010 - "The effects of MDA19 in reversing neuropathic pain were assessed in various neuropathic pain models in rats and in CB2(+/+) and CB2(-/-) mice. " 07/01/2010 - "Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain."
4.	Hyperalgesia 07/01/2010 - "MDA19 attenuated tactile allodynia produced by spinal nerve ligation or paclitaxel in a dose-related manner in rats and CB2(+/+) mice but not in CB2(-/-) mice, indicating that CB2 receptors mediated the effects of MDA19. "
5.	Hepatocellular Carcinoma (Hepatoma) 01/01/2019 - "MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway."

Related Drugs and Biologics

1.	Paclitaxel (Taxol)
2.	Ligands
3.	Cannabinoids

Related Therapies and Procedures

1.	Ligation